Portfolio company
Atometra
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Atometra automates chemical analysis through mass spectrometry to assist pharmaceutical companies with drug discovery and development processes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
AMADTEUS
This company develops an automated miniaturised platform for rapid drug discovery and chemical synthesis to serve pharmaceutical and biotechnology organisations.
Tesorai
Tesorai develops an artificial intelligence platform for mass spectrometry proteomics analysis serving biotechnology and pharmaceutical research teams.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
Solve Chemistry
This company provides an automated laboratory platform and predictive software to optimise chemical process development for pharmaceutical, agrochemical and specialty chemical customers.
Dash Bio
This company provides automated bioanalysis assays and laboratory services for pharmaceutical firms and biotechnology startups to accelerate sample analysis and drug development.
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.